Reduced levels of N’-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival

We searched for metabolic biomarkers that may predict the prognosis of patients with intrahepatic cholangiocarcinoma (IHCC). To this end, a total of 237 serum samples were obtained from IHCC patients (n = 87) and healthy controls (n = 150), and serum metabolites were analyzed by liquid chromatograph...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyung-Hee, Joo, Jungnam, Park, Boram, Park, Sang-Jae, Lee, Woo Jin, Han, Sung-Sik, Kim, Tae Hyun, Hong, Eun Kyung, Woo, Sang Myung, Yoo, Byong Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762534/
https://www.ncbi.nlm.nih.gov/pubmed/29348849
http://dx.doi.org/10.18632/oncotarget.22607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762534/
https://www.ncbi.nlm.nih.gov/pubmed/29348849
http://dx.doi.org/10.18632/oncotarget.22607

Ejemplares similares